Figure 1 (Anastrozole Fig1)
Anastrozole Tablet, Film Coated
Product Images NDC 59651-236
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 59651-236). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Anastrozole Fig2)
This appears to be a graph displaying "Disease-free survival in months" based on the number of patients at risk who were given either "anastrozole" or "tamoxifen". The numbers listed may refer to the amount of patients at risk at specific time intervals.*
Figure 3 (Anastrozole Fig3)
This appears to be a graph showing the results of a clinical trial comparing the effectiveness of two treatments (anastrozole and tamoxifen) for an undisclosed condition over a period of time (measured in months). The x-axis shows the time elapsed, while the y-axis shows the percentage of patients who have not experienced the event (disease progression or death). The graph is a Kaplan-Meier curve and has been truncated on the y-axis for clarity. There is also a table below the graph showing the number of patients at risk for each treatment at certain time points.*
Figure 4 (Anastrozole Fig4)
This appears to be a table or graph displaying data related to an experimental treatment using a drug called Anastrolzole and a comparison with a drug called Tamoxifen. The data includes the time to event in months and the number of patients at risk. There is also a note at the bottom indicating that the vertical axis has been truncated for clarity.*
Figure 5 (Anastrozole Fig5)
Figure 6 (Anastrozole Fig6)
The text appears to be a medical graph showing the progression of a certain condition over time with two randomized treatments, anastrozole and tamoxifen. The x-axis shows time in months while the y-axis shows the proportion of the condition not progressing. The data points are marked along the graph with corresponding percentages and at-risk numbers.*
Package Label-principal Display Panel – 1 mg ((30 Tablets Bottle))
Chemical Structure (Anastrozole Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
